July 28, 2023

Federal Circuit Summary for Week Ending July 28, 2023

Download PDF

United Therapeutics Corporation v. Liquidia Technologies, Inc., No. 2022-2217, 2023-1021 (July 24, 2023) (precedential) (3-0); Patent Nos. _10,716,793; 9,593,066

Key point(s):

  • An IPR decision does not have collateral estoppel effect until that decision is affirmed or the parties waive their appeal rights.
  • A product-by-process

Related Team:

W. Bruce Patterson

Partner, Practice Head